Stay updated with breaking news from Mayah Buch. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Patients with rheumatoid arthritis who take a tumor necrosis factor inhibitor do not appear to have a consistent and significant risk for developing a demyelinating disease.
In patients hospitalised for COVID-19 with clinical hypoxia who required either no oxygen or simple oxygen only, higher dose corticosteroids significantly increased the risk of death compared with usual care, which included low-dose corticosteroids. The RECOVERY trial continues to assess the effects of higher dose corticosteroids in patients hospitalised with COVID-19 who require non-invasive ventilation, invasive mechanical ventilation, or extracorporeal membrane oxygenation.
Investegate announcements from Galapagos NV, Galapagos to present encouraging initial data from FILOSOPHY real-world arthritis study at ACR Convergence 2022
Five presentations demonstrate Galapagos' commitment to inflammation and the ulcerative colitis (UC) communityNew analyses will be presented from the SELECTION data set on prediction of response and remission
Investegate announcements from Galapagos NV, Galapagos provides further insights into the treatment of ulcerative colitis at the upcoming United European Gastroenterology (UEG) Week 2022 congress